Introduction/Overview Memantine is a pharmacotherapeutic agent primarily employed in the management of moderate to severe Alzheimer’s disease. Its development represented a significant advancement in dementia treatment, offering a mechanism of action distinct from acetylcholinesterase inhibitors. The clinical relevance of memantine is anchored in its ability to provide symptomatic relief and potentially modify disease progression in … Read more

Introduction/Overview Donepezil hydrochloride is a centrally acting, reversible acetylcholinesterase inhibitor that represents a cornerstone in the symptomatic pharmacological management of dementia of the Alzheimer’s type. Since its initial approval in the late 1990s, it has become one of the most widely prescribed agents for this indication globally. The clinical relevance of donepezil stems from its … Read more

Introduction/Overview Selegiline, also known by its chemical name L-deprenyl, represents a cornerstone agent in the management of Parkinson’s disease and occupies a unique niche in neuropsychopharmacology. Initially developed in the 1960s, its clinical introduction marked a significant advancement in the symptomatic treatment of neurodegenerative disorders. The drug’s primary mechanism involves the selective and irreversible inhibition … Read more

1. Introduction/Overview Selegiline, also known internationally as L-deprenyl, represents a cornerstone agent in the therapeutic management of neurodegenerative and neuropsychiatric disorders. As a selective and irreversible inhibitor of monoamine oxidase B (MAO-B), its introduction marked a significant advancement in the symptomatic treatment of Parkinson’s disease. The drug’s unique pharmacological profile, which extends beyond simple enzyme … Read more

Introduction/Overview Imipramine, recognized historically as the first tricyclic antidepressant (TCA), represents a cornerstone in the development of psychopharmacology. Its introduction in the late 1950s marked a significant departure from earlier treatments for depression and provided the first effective chemical therapy for major depressive disorder. Although newer classes of antidepressants have since been developed, imipramine remains … Read more

Introduction/Overview Duloxetine hydrochloride is a centrally-acting pharmacological agent classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). Its development marked a significant advancement in psychopharmacology and pain management, offering a dual mechanism distinct from earlier selective serotonin reuptake inhibitors (SSRIs). The clinical relevance of duloxetine is substantial, as it addresses multiple conditions through modulation of monoaminergic neurotransmission, … Read more

Introduction/Overview Venlafaxine is a bicyclic phenylethylamine derivative that functions as a potent antidepressant agent. It represents a significant class of psychotropic medications and is considered a first-line agent for the management of major depressive disorder and several anxiety disorders. The clinical introduction of venlafaxine marked a departure from the traditional tricyclic antidepressants and selective serotonin … Read more

Introduction/Overview Paroxetine represents a cornerstone psychopharmacological agent within the class of selective serotonin reuptake inhibitors (SSRIs). First introduced in the early 1990s, it has been extensively utilized in the management of a spectrum of mood and anxiety disorders. Its clinical relevance is underscored by its potent serotonergic activity and distinct pharmacokinetic profile, which includes significant … Read more

Introduction/Overview Sertraline is a psychotropic medication belonging to the class of selective serotonin reuptake inhibitors (SSRIs). It represents one of the most widely prescribed antidepressant agents globally, forming a cornerstone in the pharmacological management of mood and anxiety disorders. First approved for medical use in the United States in 1991, its introduction marked a significant … Read more

Introduction/Overview Quetiapine fumarate is an atypical antipsychotic medication with a broad receptor-binding profile, conferring efficacy across multiple psychiatric and neurological conditions. Initially developed as a successor to clozapine, it has become one of the most widely prescribed psychotropic agents globally due to its established efficacy and a generally favorable tolerability profile regarding extrapyramidal symptoms. Its … Read more